Evidence regarding SGLT-2 inhibitors for the management of diabetic dyslipidemia

J Clin Lipidol. 2023 May-Jun;17(3):422-423. doi: 10.1016/j.jacl.2023.04.006. Epub 2023 Apr 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Diabetes Mellitus, Type 2* / complications
  • Diabetes Mellitus, Type 2* / drug therapy
  • Dyslipidemias* / complications
  • Dyslipidemias* / drug therapy
  • Humans
  • Hypoglycemic Agents / pharmacology
  • Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

  • Sodium-Glucose Transporter 2 Inhibitors
  • Hypoglycemic Agents